checkAd

     255  0 Kommentare GILEAD  AND  GALAPAGOS  ANNOUNCE  POSITIVE  EUROPEAN  CHMP  OPINION  FOR  JYSELECA  (FILGOTINIB)  FOR  THE  TREATMENT  OF  ADULTS  WITH  MODERATE  TO  SEVERE  RHEUMATOID  ARTHRITIS - Seite 4


    VP IR                                                                  Senior Director Communications
    +1 781 460 1784                                                 +32 473 824 874
                                                                               
    Sofie Van Gijsel                                                  Evelyn Fox
    Senior Director IR                                               Director Communications
    +32 485 19 14 15                                                +31 6 53 591 999
    ir@glpg.com                                                        communications@glpg.com
    Seite 4 von 5
       



    Diskutieren Sie über die enthaltenen Werte



    globenewswire
    0 Follower
    Autor folgen
    RSS-Feed abonnieren

    Weitere Artikel des Autors


    Verfasst von globenewswire
    1 im Artikel enthaltener WertIm Artikel enthaltene Werte
    GILEAD  AND  GALAPAGOS  ANNOUNCE  POSITIVE  EUROPEAN  CHMP  OPINION  FOR  JYSELECA  (FILGOTINIB)  FOR  THE  TREATMENT  OF  ADULTS  WITH  MODERATE  TO  SEVERE  RHEUMATOID  ARTHRITIS - Seite 4 - Clinical Development Program of Filgotinib Demonstrated Durable Efficacy Balanced with a Consistent Safety Profile in Rheumatoid Arthritis Through 52 Weeks - Foster City, Calif., and Mechelen, Belgium, July 24 2020, 14:10 CET; regulated …